COVID-19 and Diabetes

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• Diabetes mellitus (DM) is a common comorbidity in COVID-19 patients, associated with a worse prognosis.
• The specific mechanisms linking COVID-19 severity to DM remain unclear, but inadequate glycemic control is frequently observed in hospitalized patients.
• Healthcare professionals may lack specialized diabetes management experience, and infection control measures can hinder optimal glucose monitoring and care.

Purpose of the Study:

• To analyze the influence of COVID-19 on diabetes mellitus glycemic control.
• To assess diabetes management strategies and drug therapies during the pandemic, considering lifestyle factors and patient severity.
• To evaluate the role of telemedicine in managing diabetes during and after the COVID-19 pandemic.

Main Methods:

• Review of existing literature on COVID-19 and diabetes mellitus.
• Analysis of factors affecting glycemic control in diabetic patients during the pandemic.
• Assessment of management approaches for hospitalized and critically ill diabetic COVID-19 patients.
• Consideration of telemedicine applications in diabetes care.

Main Results:

• COVID-19 poses significant challenges to maintaining adequate glycemic control in individuals with diabetes.
• Pandemic-related restrictions and healthcare system strains complicate diabetes management, affecting diet, exercise, and medication adherence.
• Telemedicine emerges as a crucial tool for remote monitoring and management of diabetes in COVID-19 patients.

Conclusions:

• Effective clinical care for diabetic COVID-19 patients requires integrated approaches, including screening, education, and diligent monitoring.
• Adapting diabetes management strategies to pandemic conditions, utilizing telemedicine, is essential for improving patient outcomes.
• Future diabetes care models should incorporate lessons learned from the pandemic to enhance resilience and accessibility.